Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.94B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $200.3K in total
- 1
- 13F holdersQ2 2026, +32 vs. previous quarter
- 636
- 13F valueReported value at the end of Q2 2026
- $2.94B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding OGN, Q2 2026
No superinvestor reported holding OGN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Organon & Co. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 (view filing)4:04 PM ET | Aug 5 | Same day | Drinane Juliana PapaHead of Mfg & Supply | SSale | −14.8K | $13.57 | −$200.3K | −44.4%18.5K after | |
| May 7, 2026 (view filing) | May 6 | 1 day | Holzbaur LynetteSVP and Corporate Controller | SSale | −26.4K | $13.35 | −$353.1K | −100.0%0 after | Amended |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Cox Carrie SmithExecutive Chair | PPurchase | +65.4K | $7.67 | +$501.6K | +524.5%77.9K after | |
| May 15, 2025 (view filing) | May 14 | 1 day | Cox Carrie SmithDirector | PPurchase | +12.5K | $8.07 | +$100.6K | New position12.5K after | |
| May 7, 2025 (view filing) | May 7 | Same day | Falcione AaronChief Human Resources Officer | PPurchase | +5.50K | $8.77 | +$48.2K | +9.6%63.0K after | |
| May 7, 2025 (view filing) | May 6 | 1 day | Weaver KirkeGen. Counsel & Corp. Secy. | PPurchase | +8.04K | $9.21 | +$74.1K | +18.1%52.5K after | |
| May 7, 2025 (view filing) | May 6 | 1 day | Karp DanielExecutive VP, Corp. Dev. | PPurchase | +3.50K | $8.24 | +$28.8K | +8.1%46.7K after | |
| May 6, 2025 (view filing) | May 5 | 1 day | Walsh Matthew MChief Financial Officer | PPurchase | +11.4K | $8.82 | +$100.5K | +8.6%144.5K after | |
| May 6, 2025 (view filing) | May 5 | 1 day | Ali KevinChief Executive Officer | PPurchase | +34.0K | $8.81 | +$299.5K | +13.7%282.7K after | |
| Feb 23, 2024 (view filing) | Feb 22 | 1 day | Weaver KirkeGen. Counsel & Corp. Secy. | PPurchase | +2.72K | $18.36 | +$49.9K | +21.8%15.2K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Organon & Co. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 32,056,866 | $434.0M | 0.01% | +339,838+1.1% | Added |
| Pentwater Capital Management LP | 18,100,000 | $245.1M | 1.96% | +18,100,000 | New |
| Vanguard Portfolio Management LLC | 15,132,118 | $204.9M | 0.01% | −6,713,918−30.7% | Reduced |
| Vanguard Capital Management LLC | 11,909,865 | $161.3M | 0.00% | +172,847+1.5% | Added |
| State Street Corp | 9,659,371 | $130.8M | 0.00% | −297,403−3.0% | Reduced |
| Goldman Sachs Group Inc | 5,199,002 | $70.4M | 0.01% | +3,593,677+223.9% | Added |
| UBS Group AG | 4,856,529 | $65.8M | 0.01% | +1,384,950+39.9% | Added |
| Geode Capital Management, LLC | 4,815,610 | $65.2M | 0.00% | +56,273+1.2% | Added |
| Man Group plc | 4,180,500 | $56.6M | 0.10% | +4,180,500 | New |
| CNH Partners LLC | 3,880,354 | $52.4M | 0.75% | +3,880,354 | New |